These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18341375)

  • 41. Clinical practice. Graves' ophthalmopathy.
    Bartalena L; Tanda ML
    N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
    [No Abstract]   [Full Text] [Related]  

  • 42. [Graves' orbitopathy].
    Eckstein A; Esser J
    Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orbital lymphoma associated with Graves' disease: A case report.
    Hajduković Z; Kuzmić-Janković S; Kljaković-Avramović T; Sekulović L; Tukić L
    Vojnosanit Pregl; 2014 May; 71(5):510-4. PubMed ID: 26137719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A decade of thyroidology.
    Perros P
    Hormones (Athens); 2018 Dec; 17(4):491-495. PubMed ID: 30306416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strabismus in Graves' orbitopathy.
    Lyons CJ; Rootman J
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():227-9. PubMed ID: 20467368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of Graves' orbitopathy.
    Putta-Manohar S; Perros P
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():182-5. PubMed ID: 20467360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
    Bartalena L
    J Clin Endocrinol Metab; 2011 Mar; 96(3):592-9. PubMed ID: 21190983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Graves' ophthalmopathy and dermopathy. Preface.
    Wiersinga WM
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):227. PubMed ID: 22632360
    [No Abstract]   [Full Text] [Related]  

  • 49. Interpretation of Chinese Society of Endocrinology consensus statement on hyperglycemia management target in adult inpatients in China.
    Lü QG; Tong NW
    J Diabetes; 2013 Dec; 5(4):416-20. PubMed ID: 23586772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
    Mourits MP
    Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
    [No Abstract]   [Full Text] [Related]  

  • 51. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
    Marcocci C; Brandi ML; Scillitani A; Corbetta S; Faggiano A; Gianotti L; Migliaccio S; Minisola S
    J Endocrinol Invest; 2015 May; 38(5):577-93. PubMed ID: 25820553
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of new therapies in Graves' disease and thyroid-associated ophthalmopathy: animal models and translation to human clinical trials.
    Banga JP; Nielsen CH; Gilbert JA; El Fassi D; Hegedus L
    Thyroid; 2008 Sep; 18(9):973-81. PubMed ID: 18752425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric aspects in Graves' orbitopathy.
    Gogakos AI; Boboridis K; Krassas GE
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():234-44. PubMed ID: 20467370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thyroid-associated orbitopathy: who and how to treat.
    Dickinson J; Perros P
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):373-88, ix. PubMed ID: 19328417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
    Azzam I; Tordjman K
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A treatment strategy for Graves' orbitopathy.
    Marcocci C; Pinchera A; Marinò M
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
    Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
    Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and management of thyroid orbitopathy.
    Rose JG; Burkat CN; Boxrud CA
    Otolaryngol Clin North Am; 2005 Oct; 38(5):1043-74. PubMed ID: 16214573
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of genetics in Graves' disease and thyroid orbitopathy.
    Kim N; Hatton MP
    Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Corticosteroids and radiotherapy in the treatment of Graves' ophthalmopathy].
    Nasr E; Khater S; Nehme-Nasr D; Azoury F; Jambart S
    J Med Liban; 2010; 58(2):86-90. PubMed ID: 20549894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.